Ignite Creation Date:
2025-12-25 @ 4:58 AM
Ignite Modification Date:
2025-12-26 @ 3:58 AM
Study NCT ID:
NCT01050218
Status:
TERMINATED
Last Update Posted:
2023-12-11
First Post:
2010-01-13
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Study Evaluating the Long-Term Safety of Desvenlafaxine Succinate Sustained-Release (DVS SR) in Subjects With Pain Associated With Diabetic Peripheral Neuropathy
Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-07
Start Date Type:
None
Primary Completion Date:
2009-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-01
Completion Date Type:
ACTUAL
First Submit Date:
2010-01-13
First Submit QC Date:
None
Study First Post Date:
2010-01-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2010-01-29
Results First Submit QC Date:
None
Results First Post Date:
2010-05-11
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-12-07
Last Update Post Date:
2023-12-11
Last Update Post Date Type:
ACTUAL